Paul Chervinsky

Summary

Country: USA

Publications

  1. ncbi request reprint Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates, Dartmouth, Massachusetts 02747, USA
    Ann Allergy Asthma Immunol 91:160-7. 2003
  2. ncbi request reprint Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates Inc, North Dartmouth, Massachusetts 02747, USA
    Ann Allergy Asthma Immunol 99:69-76. 2007
  3. doi request reprint Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler
    Paul Chervinsky
    Northeast Medical Research Associates, Dartmouth, Massachusetts 02747, USA
    Ann Allergy Asthma Immunol 101:463-73. 2008
  4. ncbi request reprint Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates, 49 State Road, Suite 203, North Dartmouth, MA 02747, USA
    Allergy Asthma Proc 26:391-6. 2005
  5. ncbi request reprint Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma
    William E Berger
    Allergy and Asthma Associates, Mission Viejo, California 92691, USA
    Ann Allergy Asthma Immunol 97:672-80. 2006
  6. ncbi request reprint Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial
    Marc F Goldstein
    The Asthma Center, Philadelphia, PA 19107 1578, USA
    Med Sci Monit 8:CR297-304. 2002
  7. ncbi request reprint A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge
    William Storms
    Asthma and Allergy Associates, Colorado Springs, CO, USA
    Respir Med 98:1051-62. 2004
  8. ncbi request reprint Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma
    Jacob L Pinnas
    University of Arizona School of Medicine, Tucson, Arizona, USA
    J Asthma 42:865-71. 2005
  9. doi request reprint The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma
    William W Busse
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, J5 219 CSC, Box 2454, 600 Highland Ave, Madison, WI 53792, USA
    J Allergy Clin Immunol 121:1167-74. 2008

Detail Information

Publications9

  1. ncbi request reprint Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates, Dartmouth, Massachusetts 02747, USA
    Ann Allergy Asthma Immunol 91:160-7. 2003
    ..Treatment with omalizumab, an anti-IgE antibody, improves symptoms and quality of life in patients with seasonal allergic rhinitis but has not previously been investigated in patients with perennial symptoms...
  2. ncbi request reprint Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates Inc, North Dartmouth, Massachusetts 02747, USA
    Ann Allergy Asthma Immunol 99:69-76. 2007
    ..However, the long-term safety and efficacy of ciclesonide are unknown...
  3. doi request reprint Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler
    Paul Chervinsky
    Northeast Medical Research Associates, Dartmouth, Massachusetts 02747, USA
    Ann Allergy Asthma Immunol 101:463-73. 2008
    ..Patient-reported outcomes (PROs) are important for evaluating asthma therapy...
  4. ncbi request reprint Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis
    Paul Chervinsky
    Northeast Medical Research Associates, 49 State Road, Suite 203, North Dartmouth, MA 02747, USA
    Allergy Asthma Proc 26:391-6. 2005
    ..therapy was more effective in reducing total symptom scores of SAR, including nasal congestion, than were the individual components. These results support the use of this combination therapy over desloratadine or pseudoephedrine alone...
  5. ncbi request reprint Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma
    William E Berger
    Allergy and Asthma Associates, Mission Viejo, California 92691, USA
    Ann Allergy Asthma Immunol 97:672-80. 2006
    ..Mometasone furoate dry powder inhaler (DPI) has been shown to effectively treat asthma in children...
  6. ncbi request reprint Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial
    Marc F Goldstein
    The Asthma Center, Philadelphia, PA 19107 1578, USA
    Med Sci Monit 8:CR297-304. 2002
    ..This trial was designed to compare the efficacy and safety of doxofylline, theophylline, and placebo in patients with chronic reversible bronchial asthma...
  7. ncbi request reprint A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge
    William Storms
    Asthma and Allergy Associates, Colorado Springs, CO, USA
    Respir Med 98:1051-62. 2004
    ..To compare the effects of addition of montelukast or salmeterol to inhaled corticosteroids (ICS) on the response to rescue beta2-agonist use after exercise-induced bronchoconstriction...
  8. ncbi request reprint Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma
    Jacob L Pinnas
    University of Arizona School of Medicine, Tucson, Arizona, USA
    J Asthma 42:865-71. 2005
    ..The incidence of adverse events and 24-hour urine cortisol excretion rates were similar between active treatments and placebo...
  9. doi request reprint The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma
    William W Busse
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, J5 219 CSC, Box 2454, 600 Highland Ave, Madison, WI 53792, USA
    J Allergy Clin Immunol 121:1167-74. 2008
    ....